Assessing the burden of Clostridium difficile infections for hospitals

被引:3
|
作者
Hebbinckuys, E. [1 ]
Marissal, J. -P. [2 ]
Preda, C. [3 ,4 ]
Leclercq, V. [1 ]
机构
[1] Ctr Hosp St Philibert, Lomme Les Lille, France
[2] Inst Catholique Lille, Fac Gest Econ & Sci, CS 40109, F-59016 Lille, France
[3] CNRS, UMR 8524, Lab Math Paul Painleve, Villeneuve Dascq, France
[4] Romanian Acad, Inst Math Stat & Appl Math, Bucharest, Romania
关键词
Cost; Measurement bias; Nosocomial infection; TIME-DEPENDENT BIAS; LENGTH-OF-STAY; NOSOCOMIAL INFECTION; MULTISTATE MODELS; PROLONGATION;
D O I
10.1016/j.jhin.2017.08.023
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Nosocomial infections place a heavy burden on the healthcare system. However, quantifying the burden raises many questions, ranging from the way to accurately estimate the extra length of stay at hospital to defining and costing the preventive methods among the different care providers. Aim: To estimate the cost of nosocomial infection by C. difficile to inform the hospital managers. Methods: Multi-state modelling based on Markov processes and bootstrapping was used to derive individual estimates of the prolongation of stay at hospital associated with Clostridium difficile infection (CDI). Indicators of cost for hospitals were then computed, including an estimation of the productivity losses derived from diagnosis-related group (DRG)-based payment systems. Patients were aged >= 55 years, admitted in two hospital facilities in Lille, with and without an episode of CDI from January 1st, 2013 to September 15th, 2014. Findings: A total of 52 episodes were screened during the study period. The estimated mean cost of CDI was approximately is an element of 23,909 (SD: 17,458) for an extended length of hospital stay (N = 27). In the case of a reduced length of hospital stay (N = 25), the mean cost was approximately is an element of 14,697 (SD: 16,936), which represents net savings for the hospitals. The main cost/savings driver was the productivity losses/gains resulting from the nosocomial infection. A sensitivity analysis showed that the main factor explaining the amount of costs or savings due to nosocomial infections was the length of the hospital stay. Conclusion: The notion of productivity gains in the case of deaths as a factor revealing the incompleteness of the payment systems is discussed, followed by the methodological issues associated with the statistical method used to control for temporality bias. (C) 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [1] Predictors of Clostridium difficile colitis infections in hospitals
    Ricciardi, R.
    Harriman, K.
    Baxter, N. N.
    Hartman, L. K.
    Town, R. J.
    Virnig, B. A.
    EPIDEMIOLOGY AND INFECTION, 2008, 136 (07): : 913 - 921
  • [2] Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective
    Leblanc, Soline
    Blein, Cecile
    Andremont, Antoine
    Bandinelli, Pierre-Alain
    Galvain, Thibaut
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2017, 38 (08): : 906 - 911
  • [3] Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals
    Dubberke, Erik R.
    Gerding, Dale N.
    Classen, David
    Arias, Kathleen M.
    Podgorny, Kelly
    Anderson, Deverick J.
    Burstin, Helen
    Calfee, David P.
    Coffin, Susan E.
    Fraser, Victoria
    Griffin, Frances A.
    Gross, Peter
    Kaye, Keith S.
    Klompas, Michael
    Lo, Evelyn
    Marschall, Jonas
    Mermel, Leonard A.
    Nicolle, Lindsay
    Pegues, David A.
    Perl, Trish M.
    Saint, Sanjay
    Salgado, Cassandra D.
    Weinstein, Robert A.
    Wise, Robert
    Yokoe, Deborah S.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 : S81 - S92
  • [4] ECCMID 2016: addressing the burden of recurrent Clostridium difficile infections
    Eckmann, Christian
    Lyon, Sue
    FUTURE MICROBIOLOGY, 2016, 11 (10) : 1217 - 1221
  • [5] Burden of Clostridium difficile Infections in Quebec by Levy et al
    Longtin, Yves
    Garenc, Christophe
    Valiquette, Louis
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (03):
  • [6] Clostridium difficile in US hospitals
    Mushtaq, Ammara
    McConnell, John
    LANCET INFECTIOUS DISEASES, 2013, 13 (11): : 920 - 921
  • [7] CLOSTRIDIUM-DIFFICILE IN HOSPITALS
    HOFFMAN, PN
    CURRENT OPINION IN INFECTIOUS DISEASES, 1994, 7 (04) : 471 - 474
  • [8] Economic burden and cost-effective management of Clostridium difficile infections
    Heimann, S. M.
    Aguilar, M. R. Cruz
    Mellinghof, S.
    Vehreschild, M. J. G. T.
    MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (01): : 23 - 29
  • [9] THE BURDEN OF CLOSTRIDIUM DIFFICILE (CDI) INFECTION IN HOSPITALS, IN DENMARK, FINLAND, NORWAY AND SWEDEN
    Nordling, S.
    Anttila, V. J.
    Noren, T.
    Cockburn, E.
    VALUE IN HEALTH, 2014, 17 (07) : A670 - A670
  • [10] The economic burden of Clostridium difficile
    McGlone, S. M.
    Bailey, R. R.
    Zimmer, S. M.
    Popovich, M. J.
    Tian, Y.
    Ufberg, P.
    Muder, R. R.
    Lee, B. Y.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (03) : 282 - 289